Cargando…

Induction mechanism of ferroptosis: A novel therapeutic target in lung disease

Ferroptosis is a newly discovered form of non-apoptotic regulatory cell death driven by iron-dependent lipid peroxidation. Ferroptosis significantly differs from other forms of cell death in terms of biochemistry, genetics, and morphology. Ferroptosis affects many metabolic processes in the body, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Lingyu, Gong, Chunxia, Sun, Yehong, Jiang, Yeke, Duan, Xianchun, Han, Yanquan, Wang, Yongzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780473/
https://www.ncbi.nlm.nih.gov/pubmed/36569297
http://dx.doi.org/10.3389/fphar.2022.1093244
_version_ 1784856846815723520
author Pan, Lingyu
Gong, Chunxia
Sun, Yehong
Jiang, Yeke
Duan, Xianchun
Han, Yanquan
Wang, Yongzhong
author_facet Pan, Lingyu
Gong, Chunxia
Sun, Yehong
Jiang, Yeke
Duan, Xianchun
Han, Yanquan
Wang, Yongzhong
author_sort Pan, Lingyu
collection PubMed
description Ferroptosis is a newly discovered form of non-apoptotic regulatory cell death driven by iron-dependent lipid peroxidation. Ferroptosis significantly differs from other forms of cell death in terms of biochemistry, genetics, and morphology. Ferroptosis affects many metabolic processes in the body, resulting in disruption of homeostasis, and is related to many types of lung disease. Although current research on ferroptosis remains in the early stage, existing studies have confirmed that ferroptosis is regulated by a variety of genes, mainly involving changes in genes involved in iron homeostasis and lipid peroxidation metabolism. Furthermore, the mechanism of ferroptosis is complex. This review summarizes the confirmed mechanisms that can cause ferroptosis, including activation of glutathione peroxidase 4, synthesis of glutathione, accumulation of reactive oxygen species, and the influence of ferrous ions and p53 proteins. In recent years, the mechanism of ferroptosis in the occurrence and development of many diseases has been studied; the occurrence of ferroptosis will produce an inflammatory storm, and most of the inducing factors and pathological manifestations of lung diseases are also inflammatory reactions. Therefore, we believe that the association between ferroptosis and lung disease deserves further study. This article aims to help readers to better understand the mechanism of ferroptosis, provide new ideas and targets for the treatment of lung diseases, and point out the direction for the development of new targeted drugs for the clinical treatment of lung diseases.
format Online
Article
Text
id pubmed-9780473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97804732022-12-24 Induction mechanism of ferroptosis: A novel therapeutic target in lung disease Pan, Lingyu Gong, Chunxia Sun, Yehong Jiang, Yeke Duan, Xianchun Han, Yanquan Wang, Yongzhong Front Pharmacol Pharmacology Ferroptosis is a newly discovered form of non-apoptotic regulatory cell death driven by iron-dependent lipid peroxidation. Ferroptosis significantly differs from other forms of cell death in terms of biochemistry, genetics, and morphology. Ferroptosis affects many metabolic processes in the body, resulting in disruption of homeostasis, and is related to many types of lung disease. Although current research on ferroptosis remains in the early stage, existing studies have confirmed that ferroptosis is regulated by a variety of genes, mainly involving changes in genes involved in iron homeostasis and lipid peroxidation metabolism. Furthermore, the mechanism of ferroptosis is complex. This review summarizes the confirmed mechanisms that can cause ferroptosis, including activation of glutathione peroxidase 4, synthesis of glutathione, accumulation of reactive oxygen species, and the influence of ferrous ions and p53 proteins. In recent years, the mechanism of ferroptosis in the occurrence and development of many diseases has been studied; the occurrence of ferroptosis will produce an inflammatory storm, and most of the inducing factors and pathological manifestations of lung diseases are also inflammatory reactions. Therefore, we believe that the association between ferroptosis and lung disease deserves further study. This article aims to help readers to better understand the mechanism of ferroptosis, provide new ideas and targets for the treatment of lung diseases, and point out the direction for the development of new targeted drugs for the clinical treatment of lung diseases. Frontiers Media S.A. 2022-12-09 /pmc/articles/PMC9780473/ /pubmed/36569297 http://dx.doi.org/10.3389/fphar.2022.1093244 Text en Copyright © 2022 Pan, Gong, Sun, Jiang, Duan, Han and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pan, Lingyu
Gong, Chunxia
Sun, Yehong
Jiang, Yeke
Duan, Xianchun
Han, Yanquan
Wang, Yongzhong
Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title_full Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title_fullStr Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title_full_unstemmed Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title_short Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
title_sort induction mechanism of ferroptosis: a novel therapeutic target in lung disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780473/
https://www.ncbi.nlm.nih.gov/pubmed/36569297
http://dx.doi.org/10.3389/fphar.2022.1093244
work_keys_str_mv AT panlingyu inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT gongchunxia inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT sunyehong inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT jiangyeke inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT duanxianchun inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT hanyanquan inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease
AT wangyongzhong inductionmechanismofferroptosisanoveltherapeutictargetinlungdisease